News Center
Shanghai Municipal Party Secretary Han Zheng Visits SIIC and Shanghai Pharma

On July 6, Han Zheng, member of the Political Bureau of the CPC Central Committee and Shanghai Municipal Party Secretary, paid a visit to Shanghai Pharma SINE. Han Zhen was accompanied by Zhou Bo, member of the Standing Committee of the Municipal Party Committee and Executive Vice Mayor of Shanghai and Zhuge Yujie, member of the Standing Committee of the Municipal Party Committee and Secretary-General of the Municipal Party Committee of Shanghai.

First of all, Han Zheng came to the showroom of Shanghai Pharma SINE, where he heard introductions about a century-long development history of Shanghai Pharma SINE. SINE briefed the Party Secretary about the progress made in attainment of industrial structure adjustment, capacity upgrading and intelligent manufacturing, while highlighting the production and R&D, quality system, social responsibility, Party building brand and development vision. The pharmaceutical company demonstrated its confidence and determination to keep seeking development to become a cutting-edge dream factory with a century old SINE brand and a ten-billion-yuan-worth business scale. In the SINE Microecological Preparation Building, Han Zheng visited the state-of-the-art preparation production lines and learned about how Shanghai Pharma SINE strives to accelerate the R&D of microecological preparations so as to maintain its leading position in China.

During the tour, Han Zheng was briefed on the latest progress achieved by SIIC and Shanghai Pharma in terms of integration of finance and industry, innovative development and endeavors to build a comprehensive industrial group with international competitiveness. Zhou Jun, President of SIIC and Chairman of Shanghai Pharma, briefed Han Zheng about Shanghai Pharma’s business layout, integration of business segments, R&D and innovation and field exploration. Detailed introduction was made about the development process and strategic layout in enhancing manufacturing capacity, promoting the R&D of innovative drugs, consolidating the leading advantage in distribution, strengthening the competitiveness of the industrial chain, and extending the big health field. Zhou put forward Shanghai Pharma’s “13th Five-Year Plan Period” development objective to rank among Fortune Global 500 and Top 40 global pharmaceutical companies as well as the development vision to become a brand drug manufacturer and healthcare provider with global influence in the future. Wang Wei, Party Secretary and President of SIIC, said that in recent years, by deepening the integration of finance and industry, bringing such advantages as strategic integration, comprehensive industrial operation, blended mechanisms and versatile talents into full play by way of joint actions and capital operation both at home and abroad, SIIC has promoted the rapid development of the pharmaceutical, environmental protection and other industries. With such development strategy as “deepened capitalization, re-internationalization, focusing on big health and exploring new frontiers” established, endeavors will be made to build SIIC into a leading industrial investment and innovative development platform in China with good international reputation.

Han Zheng highly affirmed the development achievements obtained by SIIC and Shanghai Pharma and their efforts to steadily promote the various reform and innovation work in recent years. Han believed that as the market keeps opening up and changing frequently, h SIIC and Shanghai Pharma prove to have passed through a market-oriented road very stably and soundly. Han stressed that facing the new situations and new tasks, efforts should be made to realize the development of a higher level at a higher starting point, unswervingly deepen the reform of State-owned assets and enterprises, seek innovative development, further clarify the positioning, improve mechanisms and systems and make the main business bigger and stronger, so as to become a market entity with abundant vitality and competiveness. SIIC should stick to its clear positioning of “being based in Hong Kong, relying on Shanghai, serving national strategies and seeking internationalized development”, and Group’s development strategy, capital operation, management appraisals and building of talent team should be based on such positioning. In the process of serving national strategies and quickening the pace of going global, effective measures shall be taken to resolve talent bottleneck and attract talents from around the world, so as to render solid support to help the company achieve greater development.

Han Zheng said that Shanghai Pharma has made remarkable progress in the past few years with crystal clear approaches in terms of business integration, development ideas and strategic objectives. The Municipal Party Committee and the Municipal Government will render full support to boost the Group’s exploration in the healthcare industry. It is hoped that Shanghai Pharma will focus on its main business, fully demonstrate its expertise and bring its advantage in the production and logistics fields into full play, while striving to strengthen the weakness in pharma R&D, so as to make the pharmaceutical segment one of SIIC’s core industries and keep working hard to become a bigger and stronger player.

The top management of SIIC and Shanghai Pharma attended the occasion.

 

The subject of concern
Produced By 大汉网络 大汉版通发布系统